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Introduction
The single-nucleotide polymorphism (SNP) rs1344706 within the second intron of ZNF804A was the first to show genome-wide significant association for the broad psychosis phenotype (1) . Subsequent studies have confirmed association between common variants in ZNF804A and both schizophrenia (SCZ) and bipolar disorder (BP) (2, 3) . Additionally, copy number variations (CNVs) and chromosomal abnormalities affecting the ZNF804A gene have also been identified in cases of SCZ, BP, anxiety disorders and autism spectrum disorders (ASD) (4-7). While the rs1344706 SNP has been associated with brain function and structure (8, 9) , relatively little is known about the cellular functions of ZNF804A.
In silico modelling has revealed that ZNF804A encodes a protein containing a C2H2-type zinc-finger domain (10), a motif best known for binding DNA and regulating transcription (11). Several splice variants of ZNF804A have also been identified (10), including ZNF804A E3/E4 , which has been reported to show reduced expression in patients with schizophrenia (12), and a transcript containing an alternative exon, termed exon 2.2 (13) (Supplemental Figure S1A) .
Two independent studies have shown that the risk allele of rs1344706 is associated with reduced expression of ZNF804A RNA in the human fetal brain (12, 14) . Knockdown of ZNF804A in human neural progenitor cells (hNPCs) or in developing neurons derived from human induced pluripotent stem cells (hiPSCneurons) results in altered expression of genes involved in cell adhesion, neurite outgrowth and synapse formation, as well as cytokine signaling (15, 16) . Similarly, Deans et al. 4 overexpression of ZNF804A in rat neural progenitor cells (NPCs) has been reported to alter the expression of several genes associated with SCZ (17) . This latter study further localized the rat homologue of ZNF804A, Zfp804A, to the nucleus of rat NPCs (17) . More recently, ZNF804A/Zfp804A has also been found along neurites of developing rat neurons (18) and in extranuclear compartments in adult human neurons (12). However, a detailed characterisation of ZNF804A/Zfp804A subcellular distribution has not been performed to date. Critically, the role of this protein in regulating neuronal morphology and function has yet to be determined.
In this study, we demonstrate that ZNF804A localizes to nuclear and extranuclear compartments in hNPCs and is found at putative synapses in neurons differentiated from hNPCs or hiPSCs. Using an siRNA-based approach, we find that loss of ZNF804A attenuates the development of early neuronal morphology.
Moreover, we show that ZNF804A knockdown results in reduced expression of the adhesion protein neuroligin-4 (NLGN4), and that overexpression of NLGN4 rescues aberrant neurite outgrowth in ZNF804A knockdown neurons. In mature neurons, superresolution microscopy reveals that Zfp804A is located at the base of spines as well as at perisynaptic domains within the spine head. Here, Zfp804A is present in distinct nanodomains that contain the synaptic protein PSD-95 and NMDA receptor subunits. Finally, knockdown of Zfp804A in mature cortical neurons causes a loss of dendritic spine density, and impairs activity-dependent structural plasticity. These data reveal a novel subcellular distribution for ZNF804A/Zfp8084A as well as determining a functional role in the formation of early neuronal morphology and the regulation of excitatory synapses. Deans et al.
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Materials and Methods
Please see Supplemental Information for further detailed Materials and Methods.
CTX0E16 hNPC and neurons
Experiments using hNPCs were carried out using the CTX0E16 neural cell line obtained from ReNeuron Ltd (www.reneuron.com) under a Material Transfer Agreement. This karyotypically normal hNPC line was derived from 12 week fetal cortical neuroepithelium and conditionally immortalized using a c-mycER TAM transgene (19, 20) . Proliferation and neuralization of CTX0E16 cells were carried out as previously described (19) . Briefly, neuralization was achieved by replacing DMEM:F12 medium with Neurobasal Medium supplemented with B27 supplement (Life Technologies).
Structured illumination microscopy (SIM)
SIM imaging was carried out on primary rat cortical neurons transfected with GFP and co-immunostained for ZNF804A (Genetex) and either PSD-95 or GluN1.
Images were acquired with a Nikon N-SIM super-resolution microscope. Acquisition was performed in a 3D SIM mode using the 100X 1.49 NA TIRF objective lens with 13-25 z-steps per stack at a step interval of 0.12 µm. Image reconstructions were performed with Nikon N-SIM software. Final images, including z-projections and brightness and contrast adjustments, were carried out in ImageJ and Metamorph.
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Results
Subcellular distribution of ZNF804A in human NPCs and neurons
We first examined the subcellular distribution of ZNF804A in a conditionally immortalized human neural cell line, CTX0E16 (19) . PCR analysis of oligo(dT)primed cDNA showed expression of ZNF804A exon 4 (included in ZNF804A variant b (10) and E2E3 (12) as well as full-length ZNF804A transcripts) in proliferating CTX0E16 cells and during their early neuronal differentiation (Supplemental Figure   S1B ). Expression of exon 2.2 (13) and E2E3 (12) was also detected in these cells at the assayed timepoints using transcript-specific primers (Supplemental Figure   S1B ). However, quantitative PCR (qPCR) analysis revealed that transcripts probed by ZNF804A exon4 primers were far more abundant than ZNF804A E3/E4 alone in both proliferative and differentiated CTX0E16 cells (Supplemental Figure S1C) .
Interestingly, ZNF804A exon4 levels were significantly reduced as CTX0E16-NPCs differentiated into neurons, whereas ZNF804A E3/E4 expression was unaltered. Figure S1C) . To examine the distribution of ZNF804A we used an antibody raised against the C-terminal region (C2C3; Genetex). This antibody detected a major protein band at ~135 kDa corresponding to full length ZNF804A in
(Supplemental
DD30 CTX0E16-neuronal lysates (see Supplemental Figures S1-S5 and
Supplemental Results for additional information). Importantly, 2 previously characterized small interfering RNAs (siRNAs) targeting ZNF804A (15) specifically reduced this major protein band ( Figure 1A) indicating that this antibody is specific for full length ZNF804A; both siRNAs also reduced ZNF804A exon4 mRNA expression (Supplemental Figure S1H ).
Using the C2C3 antibody, we examined the cellular distribution of ZNF804A in CTX0E16-hNPCs (DD0) and differentiated neurons (DD28). ZNF804A was present 7 in the nuclei of hNPCs and DD28 neurons ( Figure 1B) but was also observed in the soma and processes of hNPCs, and along MAP2-positive dendrites in DD28 neurons ( Figure 1B) . A similar distribution was also seen in DD10 and DD15 CTX0E16-neurons (Supplemental Figure S4A) . In CTX0E16-NPC and hEK293 cells, exogenously expressed GFP-ZNF804A also localized to the nucleus, soma and at the plasma membrane (Supplemental Figure S4B) . Exogenously expressed myc-ZNF804A in DD7 CTX0E16-neurons, also localized along doublecortin-positive neurites further supporting an extranuclear distribution in neurons (Supplemental Figure S4C ). Furthermore, expression of a Halo-tagged ZNF804A construct in SH-SY5Y cells also displayed an extranuclear distribution in both live and fixed cells (Supplemental Figure S5A,B) . Interestingly, ZNF804A staining was more abundant in the nucleus as compared to the soma in CTX0E16-NPCs. Conversely, in CTX0E16-neurons ZNF804A immunoreactivity was greater in the soma compared to the nucleus (Figure 1C) , indicating that the distribution of the protein changed over time with the development of a neuronal morphology. Collectively, these data indicate that ZNF804A is predominately present in the nucleus of hNPCs, but is more abundant in extranuclear locations in neurons.
ZNF804A is present along dendrites and co-localizes with synaptic proteins
Examination of DD28 CTX0E16-neurons revealed ZNF804A immunoreactive staining as punctate structures in the nucleus, cell soma and along MAP2-positive dendrites (Figure 1D,E) . In distal MAP2-postive dendrites, a subpopulation of ZNF804A puncta (~44%) co-localized with the prototypical synaptic marker, PSD-95 ( Figure 1E,F) . Moreover, ~40% of ZNF804A puncta co-localized with the NMDA receptor subunit, GluN1 (Figure 1E,F) . In DD35 CTX0E16-neurons expressing eGFP, ZNF804A puncta were observed along dendrites as well as within filopodialike dendritic protrusions, further suggesting that the protein is targeted to postsynaptic compartments (Figure 1G) . These data suggest that ZNF804A is targeted to dendrites and furthermore, partially localizes to putative synapses in developing neurons.
ZNF804A regulates early neurite formation
As previous studies have suggested that ZNF804A regulates the expression of genes involved in cell adhesion, neurite outgrowth and synaptic transmission (15, 19) , we reasoned that ZNF804A might influence the development of early neuronal morphology. Using siRNAs, we reduced ZNF804A expression in CTX0E16-neurons and examined neurite outgrowth after 7 days of differentiation. ZNF804A protein levels were reduced by between 30-40% by siRNA#1 and siRNA#2 respectively Figure 2A ,B). ZNF804A has been suggested to control the expression of NLGN4X (16), a member of the neuroliginneurexin family of adhesion proteins. This protein is associated with ASDs, localizes to, and regulates synapse density (21, 22) . Intriguingly, we observed a significant reduction in NLGN4 levels in cell lysates from ZNF804A-siRNA CTX0E16-neurons; the adhesion protein N-cadherin and GluA2-AMPA receptor subunit were unaffected ( Figure 2C ). NLGN4 has been suggested to be involved in neurite outgrowth (23), however, this has not been validated. Nevertheless, we reasoned that if NLGN4 was important for neurite outgrowth, that exogenous expression of this protein would rescue deficits in neurite length in siRNA treated cells. Consistent with this, total neurite length in siRNA#1 or #2 treated cells, overexpressing HA-NLGN4 was significantly increased compared to siRNA alone conditions, but did not differ to control conditions (Figure 2E,F) . Collectively, these data demonstrate that ZNF804A plays a role in early neuritogenesis in human neurons, an effect that may be mediated via the control of NLGN4 expression.
ZNF804A localizes to synapses and regulates neuritogenesis in hiPSCneurons
HiPSCs provide a novel cellular system in which to confirm and elucidate the impact of genetic variations on cellular phenotypes (24) (25) (26) . We were therefore interested in determining whether the distribution of ZNF804A and its purported role in neuritogenesis could be recapitulated in hiPSC-neurons. HiPSCs were differentiated using a protocol that robustly generates forebrain excitatory neurons (27, 28) . In D35 hiPSC-neurons ZNF804A was detected in the nucleus, soma and along the dendrites of MAP2-positive hiPSCneurons ( Figure 3A) . ZNF804A was also observed as punctate structures along distal portions of MAP2-positive dendrites ( Figure 3B) . As with CTX0E16-neurons, a subset of ZNF804A puncta (~39%) co-localized with PSD-95 (Figure 3B,C) and approximately 45% co-localized with GluN1 (Figure 3B,C) .
To confirm a role for ZNF804A in neuritogenesis, we knocked down ZNF804A Taken together, these data demonstrate an extranuclear distribution for ZNF804A in young human neurons and furthermore, indicate that at early stages of neuronal development a subpopulation of the protein is present at putative synapses in human neurons. Moreover, these data further support a critical role for ZNF804A in neuritogenesis in young human neurons.
Zfp804A localizes to synapses in neurons with a mature morphology.
As ZNF804A has been shown to be present in adult human pyramidal neurons (12, 29) and our data suggests that ZNF804A is present at putative synapses in young neurons; we postulated that this protein may also be present at synaptic sites in mature neurons. Thus, we examined the distribution of Zfp804A in primary rat cortical neurons. Zfp804A was found to localize to nuclear and somatodendritic compartments of cortical neurons (Figure 4A, Supplemental Figure S7A ).
Along distal dendrites, Zfp804A localized to dendritic shafts and in dendritic spines (Supplemental Figure S7B,C) : 44.5±5.9% of spines were positive for Zfp804A. As spine morphology is thought to be a critical indicator of synaptic function (30, 31) , we classified dendritic spines that contained Zfp804A according to dendritic spine area.
Of spines that contained Zfp804A, the majority (71.6%) of spines had an area less than 1.0 µm 2 (Supplemental Figure S7D) . Interestingly, Zfp804A puncta were also observed along axon-like processes, indicating a potential localization at presynaptic sites (Supplemental Figure S8A) . Consistent with these immunostaining data, Western blot analysis of crude synaptosomal preparations revealed a significant enrichment of Zfp804A in synaptic lysates (Figure 4B) . Taken together, these data indicate that Zfp804A is present within the dendritic shaft and in pre-and post-synaptic structures in mature neurons.
Subsynaptic localization and organization of Zfp804A.
There is now a growing appreciation that proteins within dendritic spines are organized into subsynaptic domains (32, 33) ; the localization of these domains plays a critical role in determining the precise functional role these proteins may play (34) (35) (36) . Therefore, we were interested in the subsynaptic localization of Zfp804A within dendritic spines, as it may provide additional insights into its role at synapses. As the resolution of traditional confocal microscopy is limited to ~200 nm, we used structural illumination microscopy (SIM), a form of superresolution microscopy that exceeds this diffraction limit (37) . Using SIM we found that Zfp804A was located in nanoscopic structures along dendrites and in spines (Supplemental Figure S8B) and axon-like processes (Supplemental Figure S8C ). SIM imaging further revealed that Zfp804A was distributed into small nanoscopic domains within spine heads ( Figure 4C) ; linescan analysis further confirmed the enrichment of Zfp804A within spine heads (Figure 4C,D) . Zfp804A also localized to distinct dendritic compartments and was present at the base of dendritic spines (Figure 4C) .
Collectively, these data indicate that Zfp804A is present at discrete nanoscopic compartments in pre-and post-synaptic structures, and moreover, is distributed into small subsynaptic domains within spines.
The organization of proteins within the post synaptic density (PSD) is critical for the function of the synapse. Ultrastructural studies have shown that both PSD-95 and GluN1 are core components of the PSD (38) . Given our data showing Zfp804A can be located in spine heads (Figure 4C) , we hypothesized that Zfp804A also colocalize with synaptic proteins within spines. Confocal imaging revealed that ~52% of Zfp804A positive spines contained PSD-95, and that ~43% contained GluN1 (Supplemental Figure S8D,E) . A subset of Zfp804A puncta also co-localize with the pre-synaptic marker bassoon in mouse cortical sections (Supplemental Figure   S9A,B) . SIM imaging revealed a non-uniform distribution of Zfp804A within spine heads that was surrounded by, and only partially co-localized with, PSD-95. Intensity profiles across co-localized Zfp804A and PSD-95 in spines indicated a partial colocalization of the 2 proteins (Figure 4E, Supplemental Figure S9C ). Interestingly, Zfp804A and GluN1 partially co-localized within spine heads; this distribution was confirmed by intensity profiles of co-localized puncta (Figure 4F, Supplemental   Figure S9D ). Taken together, these data suggest that within spine heads Zfp804A predominately displays a perisynaptic localization, with a small amount of protein potentially present within the PSD.
Zfp804A is required for the maintenance of dendritic spines and activitydependent structural plasticity.
Our current data indicates that a subpopulation of Zfp804A localizes to synapses, suggesting a potential role in the maturation, or maintenance, of dendritic spines. Therefore, we knocked down Zfp804a using siRNA#2, predicted to also target Zfp804A; siRNA#2 reduced Zfp804A protein expression by ~35% (Figure 5A) .
A similar level of Zfp804A knockdown was observed by ICC (Figure 5B,C) . Neurons treated with siRNA#2 for 5 days had ~35% fewer spines compared to neurons expressing no siRNA or scramble siRNA (Figure 5D) . Interestingly, when we examined spine morphology, no difference was seen in spine area, length or breadth Deans et al.
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indicating the reduction in linear density was due to a loss of spines of no particular morphology (Figure 5E, Supplemental Figure S10A-C) . As loss of ZNF804A in young human neurons correlated with a reduced NLGN4 expression, a protein known to regulate synapse density (21, 22) , we examined whether this molecule was also affected by loss of Zfp804A expression. As predicted, NLGN4 was reduced in Zfp804A knockdown neurons whereas no changes in the adhesion protein Ncadherin or the synaptic protein SNAP25 expression were observed (Figure 5G,H) .
As altering Zfp804A expression influenced spine density, we reasoned that loss of Zfp804A may affect activity-dependent spine plasticity. Therefore, we used a well-characterized chemical LTP (cLTP) protocol shown to cause a rapid increase in spine area and density via activation of NMDA receptors (31, 39) . Application of cLTP on control cells or neurons expressing scramble siRNA resulted in a significant increase in density (~33%) and spine area (~24%) (Figure 5I,J) . However, in Zfp804A knockdown neurons, no increase in spine area was observed after cLTP treatment, although spine density increased (~35%) to a level similar to unstimulated (basal) control levels (Figure 5I,K) . Collectively, these experiments demonstrate that Zfp804a is required for spine maintenance, and that loss of the protein impairs the ability of neurons to respond fully to activity-dependent simulations.
Discussion
Variants in ZNF804A are associated with various neuropsychiatric conditions (1-6), and emerging evidence suggests that synaptic pathology may be a key cellular substrate contributing to the pathophysiology of these disorders (30) . While functional studies suggest that ZNF804A controls the expression of genes involved in cell adhesion, neurite outgrowth and synaptic transmission (15, 19) , little is known about the cellular function of this susceptibility gene. Here, we present evidence that ZNF804A/Zfp804a localizes to dendrites and synapses, in both neurons derived from either hNPC or hiPSC sources and mature rat cortical neurons. siRNA-mediated loss of ZNF804A further reveals a role in establishing early neuronal morphology, an effect potentially mediated by ZNF804A's ability to regulate the expression of the adhesion protein NLGN4, a protein implicated in ASDs (21, 22) . In mature neurons, superresoultion imaging revealed Zfp804A nanodomains at perisynaptic locations within dendritic spines, where it partially co-localizes with synaptic proteins. Critically, siRNA-mediated loss of Zfp804A resulted in a reduction in spine linear density, and impaired activity-dependent structural plasticity. Collectively, these data suggest that ZNF804A/Zfp804A is involved in early neurite outgrowth, and also plays a role in regulating spine maintenance and the ability of neurons to respond to activitydependent stimuli. Although some of these cellular effects may be governed by ZNF804A/Zfp804A's ability to regulate NLGN4 expression, ZNF804A/Zfp804a may also play a functional role at synapses and alter the expression of other synaptic proteins. Importantly, as risk variants in ZNF804A appear to alter its developmental expression (5, 12, 14) our data provide an insight into how this could contribute to the pathophysiology of psychotic and neurodevelopmental disorders.
ZNF804A has been posited as a putative transcription factor owing to the presence of a C2H2 zinc-finger domain, a motif which facilitates binding to specific DNA sequences (10, 11), and based on functional gene expression studies (15, 17, 19) . Consistent with this role, Zfp804a has been reported to localize to the nucleus of rat progenitor cells (17) . However, in silico analysis of ZNF804A has suggested that it may not act as a classical ZNF-protein as it only contains a single C2H2 motif, in contrast to other members of the zinc-finger family which typically possess multiple zinc-finger motifs (10). Our data indicates that ZNF804A is highly present within the nucleus in undifferentiated hNPCs and throughout the cell. In differentiated neurons, a higher proportion of ZNF804A is found in the somatic compartment. This pattern of distribution has also been reported in developing rat neurons (18) . Thus, ZNF804A appears to be enriched within the nuclear compartment of undifferentiated hNPCs whereas, in neurons it is distributed along dendrites, axons and synapses.
Interestingly, our data suggests that there is a change in the cellular distribution of ZNF804A during neuralization, with more protein located in the nucleus of hNPCs, and in extranuclear subcompartments in neurons. The change in distribution could be an indication of changes in isoform expression. Q-PCR analysis indicates that while ZNF804A E3/E4 expression is not altered during early neuralization, overall ZNF804A exon4 transcripts were reduced. The change in distribution could also reflect a change in the function of the protein. Indeed, the presence of ZNF804A along neurites/dendrites is consistent with our functional data revealing a role in establishing early neuronal morphology. However, it is currently unclear whether the different ZNF804A isoforms display different localisations or function differently. The recently discovered disease-associated transcript ZNF804A E3/E4 (12) lacks the C2H2-domain present in the full-length protein and thus has no obvious ability to bind DNA or act as a transcription factor. Therefore, in order to fully understand how this protein may contribute to the pathophysiology of psychiatric disorders it is critical to fully understand the distribution of all isoforms of ZNF804A and furthermore, the functional roles they play.
In developing human neurons, ZNF804A partially co-localized with both PSD-95 and GluN1. As these neurons can form immature synaptic connections (19) , it is possible that ZNF804A is functionally present at putative synapses. Interestingly, ZNF804A knockdown attenuated neuritogenesis; concurrently, these cells display reduced expression of NLGN4. NLGN4X expression has recently been shown to be downregulated in ZNF804A knockdown hiPSCs (16) , although it is not clear whether this is due to ZNF804A directly regulating NLGN4X expression. Although NLGN4 has been implicated in neuritogenesis (23) , no direct evidence has been provided demonstrating a role in neurite formation. We show that exogenous-overexpression of NGLN4 rescues aberrant neurite outgrowth observed in ZNF804A knockdown neurons. Whether this indicates that ZNF804A's effects on neurite outgrowth are dependent on the direct or indirect regulation of NLGN4 expression will need to be established in future studies.
In mature neurons, Zfp804A was predominately located along dendrites and within a subset of dendritic spines; it was also detected in axon terminals.
Superresolution imaging further revealed that Zfp804A could be found at the base of and within the head of spines. Within spine heads, Zfp804A appears to form nanodomains, which surrounds and integrates within the PSD. PSD-95 and GluN1 partially surrounded Zfp804A puncta supporting an enrichment at perisynaptic regions, and a potential participation in a larger protein complex with synaptic proteins. The presence of ZNF804A at the base of dendritic spines is also potentially interesting when taken together with previous work showing that this subsynaptic compartment is a key region where regulation of mRNA occurs (40) , and that C2H2domains can mediate protein-RNA interactions (11, 41) . We also find that loss of Zfp804A resulting in a reduction of dendritic spine density also occurred concurrently with a reduction in NLGN4 expression, which has also been implicated in the regulation of synapse density (21, 22) . However, it is not yet clear whether Zfp804A also plays a functional role locally at synapses. Interestingly our data also indicates that Zfp804A knockdown impairs rapid structural changes induced by cLTP, specifically in the enlargement of spine size. Whilst this effect could be driven by reduced expression of NLGN4 or other proteins, it is interesting to note that Zfp804A preferentially localized to small spines. It is these spines that readily undergo enlargement following cLTP (31); therefore, it is possible that Zfp804A functions locally at synapses in addition to regulating gene expression. Understanding whether Zfp804a contributes to local signaling at synapses, in addition to regulation of gene transcription, is crucial in further understanding the role of ZNF804A/Zfp804a in physiological and pathological conditions. It should be noted that although our data demonstrates a functional role for ZNF804A/Zfp804A in controlling neuronal and synaptic function based on siRNA-based approaches, interpretation of the distribution of the protein should be noted with caution. Based on our antibody characterization studies, the C2C3 antibody shows some level of non-specificity by Western blot (Supplemental Figures S1-S5) , although overexpression and knockdown studies indicate that C2C3 is specific for ZNF804A in ICC (Supplemental Figures S2-S5) . However, a true validation of antibody specificity can only be demonstrated using tissue lacking all isoforms. Nevertheless, our data examining the extracellular distribution is consistent with previously reports (12, 18), and critically, with our overexpression/knockdown experiments and functional studies.
In conclusion, we find ZNF804A/Zfp804a to be expressed in discrete structures along the dendrites and at synapses, and to have a functional role in regulating neuronal and synaptic morphology. Interestingly, the nanoscopic distribution of ZNF804A/Zfp804A in spines indicates a potential functional role in influencing local signaling at synapses. SCZ, BP and ASDs have all been shown to display overlapping cellular deficits including reduced dendritic arborization and spine density (30) . Additionally, increasing evidence suggests that risk factors implicated in these disorders converge onto a common biological function: control of neuronal and synaptic structure (30, 42) . It is therefore possible that dysregulation of ZNF804A in these disorders could also contribute to altered neuronal and synaptic structures seen in these disorders (30) . Our study further highlights how understanding the cellular function of risk proteins may reveal novel functions, but may also identify how multiple psychiatric disorders may share genetic risk factors and biological mechanisms. Scale bar = 5 µm.
